Giuseppe Viscardi

机构：University of Campania "Luigi Vanvitelli", Ospedale Monaldi · ORCID：0000-0003-4473-9387

发表论文 120 篇 · 总被引 3174 次 · h-index 25

代表论文

• Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review (2023 · Annals of Oncology · 被引 337)
• Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis (2022 · European Journal of Cancer · 被引 160)
• Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC (2024 · Journal of Thoracic Oncology · 被引 86)
• Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis (2024 · Journal of Thoracic Oncology · 被引 46)
• Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies (2023 · European Journal of Cancer · 被引 40)
• Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients (2023 · Frontiers in Oncology · 被引 40)